Cargando...
Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
Activating mutations in RAS are present in ~ 30% of human tumors, and the resulting aberrations in ERK/MAPK signaling play a central role in oncogenesis. However, the form of these signaling changes is uncertain, with activating RAS mutants linked to both increased and decreased ERK activation in vi...
Gardado en:
| Publicado en: | Mol Syst Biol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7569415/ https://ncbi.nlm.nih.gov/pubmed/33073539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/msb.20209518 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|